Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012Maurizio Delvecchio, Enza Mozzillo, Giuseppina Salzano, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 4, 2021
Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: Factors associated with cardiometabolic riskProcolo Di Bonito, Enza Mozzillo, Francesco M Rosanio, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 31, 2026
Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta-analysisRoberto Franceschi, Enza Mozzillo, Marco Marigliano, et al.Pediatrics|May 14, 2026
Screening Programs for Type 1 Diabetes in Youth: Evidence for Clinical PracticeRoberto Franceschi, Enza Mozzillo, Marco Marigliano, et al.Frontiers in Endocrinology|May 21, 2021
Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)Enza Mozzillo, Roberto Franceschi, Claudia Piona, et al.Diabetes Research and Clinical Practice|September 6, 2023
Satisfaction with continuous glucose monitoring is positively correlated with time in range in children with type 1 diabetesMarco Marigliano, Riccardo Pertile, Enza Mozzillo, et al.Acta Diabetologica|February 22, 2023
Italian translation and validation of the CGM satisfaction scale questionnaireEnza Mozzillo, Marco Marigliano, Alda Troncone, et al.Diabetic Medicine : a Journal of the British Diabetic Association|February 22, 2024
Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment typeRoberto Franceschi, Riccardo Pertile, Marco Marigliano, et al.The Journal of Clinical Endocrinology and Metabolism|November 4, 2025
Glucometabolic control and Anti-Transglutaminase Antibodies at Celiac Disease onset in Type 1 Diabetes youthFrancesca Di Candia, Francesco Maria Rosanio, Roberto Franceschi, et al.Eclinicalmedicine|March 20, 2026
Long-term efficacy and safety of Control-IQ technology in younger children with type 1 diabetes in Italy (2020-2023): a longitudinal multicentre real-world studyValentino Cherubini, Roberto Franceschi, Andrea Fargalli, et al.Pageof 8